• Netcapital received a second 180-day Nasdaq extension to regain compliance with the $1 minimum bid price rule, deadline Feb. 1, 2027.
• Non-compliance was triggered by the stock closing below $1 for 30 straight business days, prompting an initial cure period that ended Aug. 3, 2026.
• Compliance can be restored if the stock closes at or above $1 for at least 10 consecutive business days; Nasdaq may require up to 20.
• Failure to cure by Feb. 1, 2027 is expected to lead to a delisting determination; a hearing request would not stay a trading suspension.
• The company signaled it may pursue a reverse stock split to address the deficiency.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Netcapital Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608101605PRIMZONEFULLFEED9807132) on August 10, 2026, and is solely responsible for the information contained therein.